home About Us People Portfolio Contact Us Fund II Investor Login » Fund III Investor Login » Fund IV Investor Login » Fund V Investor Log In »


$45 million

Medical Device
ENT / Hearing Loss

Earlens Corporation is a privately held medical device company committed to providing hearing impaired patients with a superior hearing solution. The company has developed the Earlens Contact Hearing Aid, the first non-surgical hearing device to directly activate the hearing system, producing broad bandwidth and superior sound quality. In late 2015, the FDA cleared a De Novo premarket submission allowing Earlens to market their Contact Hearing Aid. Incorporated in 2005, Earlens Corporation is headquartered in Menlo Park, California.